These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25414398)

  • 1. Comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140.
    Rodbard HW; Karolicki B
    Diabetes Care; 2014 Dec; 37(12):e261-2. PubMed ID: 25414398
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140.
    Edelman SV; Liu R; Johnson J; Glass LC
    Diabetes Care; 2014 Dec; 37(12):e263-4. PubMed ID: 25414399
    [No Abstract]   [Full Text] [Related]  

  • 3. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes.
    Edelman SV; Liu R; Johnson J; Glass LC
    Diabetes Care; 2014 Aug; 37(8):2132-40. PubMed ID: 24742662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative combination therapy for type 2 diabetes?
    Østoft SH; Christensen M
    Lancet; 2015 May; 385(9982):2020-2. PubMed ID: 26009215
    [No Abstract]   [Full Text] [Related]  

  • 5. Concentrated insulins in current clinical practice.
    Schloot NC; Hood RC; Corrigan SM; Panek RL; Heise T
    Diabetes Res Clin Pract; 2019 Feb; 148():93-101. PubMed ID: 30583034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral treatment of type 2 diabetes mellitus].
    Palitzsch KD
    Dtsch Med Wochenschr; 2012 Sep; 137(38):1859-68, quiz 1869-72. PubMed ID: 22971973
    [No Abstract]   [Full Text] [Related]  

  • 8. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
    Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
    Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.
    Dungan KM; Buse JB; Herman WH; Arakaki RF; Jiang HH; Jacobson JG; Fahrbach JL
    Diabetes Res Clin Pract; 2012 Jun; 96(3):e66-9. PubMed ID: 22421598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical utility index for selecting an optimal insulin dosing algorithm for LY2605541 in patients with type 2 diabetes pretreated with basal insulin.
    Manner DH; Luo J; Qu Y; Berry S; Gaydos BL; Jacober SJ
    Diabetes Technol Ther; 2014 Aug; 16(8):499-505. PubMed ID: 24825416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-centred treatments for type 2 diabetes.
    Kudva YC; Montori VM
    Lancet; 2008 Mar; 371(9618):1047-8. PubMed ID: 18374823
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.
    Jendle J; Testa MA; Martin S; Jiang H; Milicevic Z
    Diabetes Obes Metab; 2016 Oct; 18(10):999-1005. PubMed ID: 27279266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To mix or to separate: that is the question.
    Cho YM
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):229-31. PubMed ID: 25754416
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Subcutaneous Regular Insulin and Lispro Insulin in Diabetics Receiving Continuous Nutrition: A Numerical Study.
    Stull MC; Strilka RJ; Clemens MS; Armen SB
    J Diabetes Sci Technol; 2015 Jun; 10(1):137-44. PubMed ID: 26134836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes.
    Vellanki P; Bean R; Oyedokun FA; Pasquel FJ; Smiley D; Farrokhi F; Newton C; Peng L; Umpierrez GE
    Diabetes Care; 2015 Apr; 38(4):568-74. PubMed ID: 25665812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes.
    Gordon J; McEwan P; Sabale U; Kartman B; Wolffenbuttel BH
    J Med Econ; 2016 Dec; 19(12):1167-1174. PubMed ID: 27356188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Insulin Lispro Protamine Suspension in Pregnancy.
    Lapolla A; Dalfrà MG; Romoli E; Bonomo M; Moghetti P
    Adv Ther; 2015 Oct; 32(10):888-905. PubMed ID: 26499176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile?
    Hood RC
    Diabetes Technol Ther; 2017 Apr; 19(4):203-205. PubMed ID: 28418731
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrating advances in insulin into clinical practice: Advances In insulin formulations.
    King A
    J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S9-17. PubMed ID: 24080573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.